IXJ · iShares Global Healthcare ETF ETF
iShares Trust
$104.90
-1.08%
At close · Sep 4
Net assets $3,844,812,651
Holdings124
1 month
+2.56%
Year to date
+8.66%
52-week range
$85.36–$107.69
30-session avg volume
180,815
Market performance
Adjusted close · up to five years
Fund profile
- Structure
- Open-end / ETF
- SEC series
- S000004372
- Report date
- Jun 30, 2026
- Holdings coverage
- Full reported portfolio
Portfolio concentration
Top 10 holdings47.79%
Calculated only when the SEC filing is stored with complete portfolio coverage.
Asset allocation
EC99.57%
STIV1.27%
DE0.02%
Country allocation
US70.64%
CH10.35%
GB5.83%
JP3.68%
DK2.30%
FR1.97%
DE1.59%
Other4.54%
Portfolio holdings
Latest linked SEC Form NPORT-P report.
| Holding | Ticker / CUSIP | Value | Weight |
|---|---|---|---|
| ELI LILLY AND COMPANY | LLY | $420,256,283 | 10.93% |
| JOHNSON & JOHNSON | JNJ | $270,785,354 | 7.04% |
| ABBVIE INC. | ABBV | $196,921,385 | 5.12% |
| UNITEDHEALTH GROUP INCORPORATED | UNH | $168,996,821 | 4.40% |
| MERCK & CO., INC. | MRK | $158,401,436 | 4.12% |
| ASTRAZENECA PLC | $144,532,200 | 3.76% | |
| Roche Holding AG | $144,151,096 | 3.75% | |
| Novartis AG | $142,812,406 | 3.71% | |
| AMGEN INC. | AMGN | $97,548,610 | 2.54% |
| THERMO FISHER SCIENTIFIC INCORPORATED | TMO | $92,984,732 | 2.42% |
| ABBOTT LABORATORIES | ABT | $78,887,813 | 2.05% |
| GILEAD SCIENCES, INC. | GILD | $78,292,645 | 2.04% |
| NOVO NORDISK A/S | $76,391,472 | 1.99% | |
| INTUITIVE SURGICAL, INC. | ISRG | $70,297,894 | 1.83% |
| PFIZER INC. | PFE | $68,502,567 | 1.78% |
| CVS HEALTH CORPORATION | CVS | $65,883,581 | 1.71% |
| VERTEX PHARMACEUTICALS INCORPORATED | VRTX | $62,929,234 | 1.64% |
| DANAHER CORPORATION | DHR | $59,889,769 | 1.56% |
| BRISTOL-MYERS SQUIBB COMPANY | BMY | $58,730,280 | 1.53% |
| STRYKER CORPORATION | SYK | $54,219,856 | 1.41% |
| GSK PLC | $53,129,444 | 1.38% | |
| MEDTRONIC PUBLIC LIMITED COMPANY | MDT | $50,131,818 | 1.30% |
| SANOFI SA | $45,521,669 | 1.18% | |
| MCKESSON CORPORATION | MCK | $45,317,866 | 1.18% |
| ELEVANCE HEALTH, INC. | ELV | $41,907,996 | 1.09% |
| BlackRock Funds III: BlackRock Cash Funds: Institutional; SL Agency Shares | 066922519 | $40,609,480 | 1.06% |
| THE CIGNA GROUP | CI | $36,396,928 | 0.95% |
| BOSTON SCIENTIFIC CORPORATION | BSX | $31,663,438 | 0.82% |
| REGENERON PHARMACEUTICALS, INC. | REGN | $31,086,587 | 0.81% |
| HCA HEALTHCARE, INC. | HCA | $30,218,424 | 0.79% |
| argenx SE | $28,619,694 | 0.74% | |
| CARDINAL HEALTH, INC. | CAH | $27,767,438 | 0.72% |
| CENCORA, INC. | COR | $27,479,622 | 0.71% |
| ESSILORLUXOTTICA SA | $27,353,994 | 0.71% | |
| Bayer Aktiengesellschaft | $27,120,528 | 0.71% | |
| HOYA CORPORATION | $26,921,185 | 0.70% | |
| EDWARDS LIFESCIENCES CORPORATION | EW | $25,995,490 | 0.68% |
| Takeda Pharmaceutical Company Limited | $25,324,144 | 0.66% | |
| HUMANA INC. | HUM | $23,798,642 | 0.62% |
| Lonza Group AG | $23,636,777 | 0.61% | |
| Galderma Group AG | H3301B107 | $20,791,424 | 0.54% |
| IDEXX LABORATORIES, INC. | IDXX | $20,722,258 | 0.54% |
| BECTON, DICKINSON AND COMPANY | BDX | $20,709,964 | 0.54% |
| HALEON PLC | $20,395,909 | 0.53% | |
| Sandoz Group AG | $19,841,370 | 0.52% | |
| CSL LIMITED | $19,325,869 | 0.50% | |
| AGILENT TECHNOLOGIES, INC. | A | $18,735,672 | 0.49% |
| WATERS CORPORATION | WAT | $18,375,835 | 0.48% |
| UCB SA | $18,014,354 | 0.47% | |
| Otsuka Holdings Co., Ltd. | $17,105,711 | 0.44% |